• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Apple announces medical studies using new Research app

Apple announces medical studies using new Research app

September 12, 2019 By Sean Whooley

Apple WatchApple (NSDQ:AAPL) said yesterday that it is launching medical studies into women’s health, hearing, and heart function and movement with its new Research app.

The Cupertino, Calif.-based company said the app will show how medical research is conducted and allow participants to contribute to potential medical discoveries. The Research app will be available as a free download later this year for the Apple watch and iPhone.

Apple’s women’s health study will focus on menstrual cycles and gynecological conditions, informing screening and risk assessment of conditions like polycystic ovary syndrome (PCOS), infertility, osteoporosis, pregnancy and menopausal transition.

The hearing study will collect data over time to examine how everyday sound exposure can affect hearing.

For its heart and movement study, Apple said it will follow heart rate and mobility signals to see how they relate to hospitalizations, falls, heart health and quality of life.

Apple’s foray into medical research began with its ResearchKit and CareKit in 2015 to study healthcare. The company used the ResearchKit to launch the Apple Heart Study, which showed that the Apple Watch is capable of aiding in the detection of atrial fibrillation using its light-sensor based technology, according to results released in March of this year.

“With the Apple Heart Study, we found that we could positively impact medical research in ways that help patients today and that make contributions that will benefit future generations,” Apple COO Jeff Williams said in the release. “Today’s announcement carries our commitment to health even further by engaging with participants on a larger scale than ever before.”

Apple plans to collaborate on the studies with the Harvard T.H. Chan School of Public Health, the NIH’s National Institute of Environmental Health Sciences, Brigham and Women’s Hospital, the American Heart Association, the University of Michigan and the World Health Organization.

Shares of AAPL were up +0.03% at $223.67 per share in early-morning trading.

Filed Under: Cardiovascular, Clinical Trials, Featured, News Well, Otolaryngology/Ear, Nose & Throat (ENT), Women's Health Tagged With: American Heart Association, Apple, Brigham & Women's Hospital, Harvard T.H. Chan School of Public Health, National Institutes of Health (NIH), World Health Organization

More recent news

  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure
  • NanoVibronix enters into $50M financing agreement

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy